SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

13 Feb 2023 Evaluate
The Turnover for the quarter ended December 2022 of Rs. 590.20 millions increase by 53.46% from Rs. 384.60 millions.Net Profit witnessed a 162.76% growth almost the double from Rs. 14.50 millions to Rs. 38.10  millions  of same quarter last year.Operating Profit saw a handsome growth to 74.60 millions from 42.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 590.20 384.60 53.46 1670.10 1597.00 4.58 2120.10 2036.70 4.09
Other Income 39.50 13.60 190.44 118.80 56.40 110.64 77.80 86.70 -10.27
PBIDT 74.60 42.00 77.62 266.70 293.00 -8.98 359.20 338.10 6.24
Interest 7.90 2.10 276.19 13.80 6.50 112.31 8.90 7.60 17.11
PBDT 66.70 39.90 67.17 252.90 286.50 -11.73 350.30 330.50 5.99
Depreciation 14.30 16.40 -12.80 44.20 51.00 -13.33 66.60 60.30 10.45
PBT 52.40 23.50 122.98 208.70 235.50 -11.38 283.70 270.20 5.00
TAX 14.30 9.00 58.89 58.10 63.20 -8.07 70.70 68.10 3.82
Deferred Tax 0.70 0.80 -12.50 1.60 -1.80 -188.89 -9.40 -2.80 235.71
PAT 38.10 14.50 162.76 150.60 172.30 -12.59 213.00 202.10 5.39
Equity 57.75 57.30 0.79 57.75 57.30 0.79 57.70 57.30 0.70
PBIDTM(%) 12.64 10.92 15.74 15.97 18.35 -12.96 16.94 16.60 2.06

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×